Diabetic Machine Without Pricking Finger is a new system, which was already approved by the Anmat, has a revolutionary technology to monitor blood sugar levels. It works with a small sensor that is placed on the arm and performs minute by minute measurements.
Glucose control is something that people with diabetes must do multiple times a day, an essential and critical step for an adequate management of the disease, mainly in those who are under insulin treatment. Knowing the blood sugar levels will allow you to adjust the diet and determine the dose of insulin that will be applied.
However, 4 out of 10 patients do not measure glucose with the frequency recommended by their doctor, either because of the pain that the puncture generates them, due to discomfort, forgetfulness, lack of strips for measurement or because of fatigue.
Now, thanks to a novel sensor that replaces punctures in the fingers to measure the level of glucose in people with diabetes, that cumbersome “procedure” will be a thing of the past.
The Abbott laboratory announced that the National Administration of Drugs, Food and Medical Technology (Anmat) has approved FreeStyle Libre, the Flash glucose monitoring system, which is a revolutionary technology for measuring glucose levels in children and adults with diabetes.
Currently, at least 60% of people with diabetes do not achieve the recommended glycemic control goals
This novel tool, which is already available in the country, contributes to a better control of diabetes, an epidemic disease that affects 1 in 10 adults in Argentina.
“Diabetes is a growing public health concern in Argentina” said Nicolás Mendiberri, general manager of Abbott Diabetes Care in Argentina.
The system consists of a small, rounded sensor, approximately the size of a two-peso coin, which is placed on the arm and which, minute by minute, measures the glucose in interstitial fluid by means of a small filament that is placed just below. the skin and stays in place attached to a small adhesive patch. People can bathe with the placed sensor. By simply bringing the reader closer, which is a device similar to a small cell phone, about 4 centimeters from the sensor, the data is automatically “scanned” in less than a second, without causing pain, and also yields a history of glucose levels in time.
The FreeStyle Libre system was introduced in Europe in 2014; It is already available in more than 37 countries and is used by more than 300 thousand people with diabetes around the world. A clinical study published in The Lancet and the experience of using more than 50 thousand people outside of studies shows that those who use the device measure their glucose at least 15 times a day. The reports also showed that those who scan more frequently have fewer episodes of hypoglycaemia and hyperglycemia, while improving their average glucose levels, which shows better control.
Although the device is already in Argentina, the Abbott laboratory is still in talks with the different actors of the health system so that it has coverage. At the moment it is going to be able to acquire in a particular way, for a value of 1,100 pesos the reader (which is acquired only once) and another 1,100 pesos the sensor that lasts 14 days.
“The pain and discomfort associated with the fingerprinting system unfortunately determines that the controls in some patients are performed less frequently than ideal, which is detrimental to the optimal management of diabetes” explained Dr. Leon Litwak, former president of the Argentine Diabetes Society and member of the Endocrinology, Metabolism and Nuclear Medicine Service of the Hospital Italiano de Buenos Aires.
Diabetes is a disease with an epidemic nature that affects 1 in 10 adults in Argentina
For him, “one of the main advantages of this system is the fact that it marks the tendencies that glucose has in the organism to rise or fall.The incorporation of the concept of tendency is very important to prevent both the rise or fall of glucose in blood. ”
Currently, at least 60% of people with diabetes do not reach the recommended glycemic control objectives and this is partly explained because “the patient must devote a lot of time, concentration and effort to the control of diabetes throughout the day “, remarked Dr. Adrián Proietti, endocrinologist, director of the Technology course applied to the control and treatment of diabetes of the Argentine Diabetes Society and Medical Director of the Integral Institute of Diabetes and Applied Technology (IDTA), who celebrated the news of that now have a new and friendly tool to monitor their glucose level.
For Adriana Angelina, who has diabetes for 35 years and chairs the Argentine Diabetes Association (ADA), the device “represents a paradigmatic advance in the management of diabetes, since it allows to monitor glucose levels systematically and identify timely trends critical, for example during the night, because the symptoms of hypoglycemia can go unnoticed when it occurs while the person is sleeping. “